Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
8 hours ago
Remote friendly (Mettawa, IL)
United States
Market Access
Responsibilities:
- Lead HEOR Strategy development of an end-to-end holistic evidence strategy for immunology (rheumatology and dermatology) assets from early proof of concept through Ph3.
- Drive matrix decision-making through the Pipeline Commercialization Model (PCM), aligning clinical development, medical, regulatory, market access, and commercial stakeholders.
- Lead Clinical Outcomes Assessment (COA) strategy: select, validate, and operationalize PROs/COAs; engage regulators on endpoint acceptability; pursue label-enabling claims and differentiation.
- Drive real-world evidence (RWE) generation to inform trial design, target populations, unmet needs, disease burden, patient journey, and future asset value.
- Guide economic value assessments (e.g., cost-effectiveness, budget impact, pricing scenarios, health-state utilities) to define product value, support pricing/reimbursement, and shape value narratives.
- Develop early integrated value propositions, value frameworks/narratives, and conduct affiliate touchpoint engagements to shape asset strategy and evidence plans.
- Collaborate with market access on global value dossiers, HTA strategies, access evidence gap closure plans, scenario analyses, and advisory engagements.
- Shape therapeutic area disease area strategies through identification/development of compelling evidence and novel endpoints.
- Communicate research findings and strategic impact to internal and external audiences.
Qualifications:
- Required: Advanced degree in Health Economics, Public Health, Epidemiology, Health Services Research, or related field (Master’s+; PhD or PharmD/MS preferred).
- Minimum experience: 8 years with Master’s or 6 years with PhD/PharmD/MS in progressively senior Health Economics, Outcomes Research, and Market Access roles.
- Strongly preferred: Experience leading COA/PRO evidence generation for pipeline assets in pharma; immunology therapeutic area experience.
- Skills: Strong executive presence/presentation; ability to resolve priority conflicts and operate under resource constraints; deep knowledge of global regulatory/payer/HTA landscape; proven cross-functional global leadership; self-starter with goal-oriented, solution-focused mindset.
Benefits:
- Paid time off (vacation, holidays, sick); medical/dental/vision insurance; 401(k) (eligible employees).
- Short-term incentive programs eligibility.
- Lead HEOR Strategy development of an end-to-end holistic evidence strategy for immunology (rheumatology and dermatology) assets from early proof of concept through Ph3.
- Drive matrix decision-making through the Pipeline Commercialization Model (PCM), aligning clinical development, medical, regulatory, market access, and commercial stakeholders.
- Lead Clinical Outcomes Assessment (COA) strategy: select, validate, and operationalize PROs/COAs; engage regulators on endpoint acceptability; pursue label-enabling claims and differentiation.
- Drive real-world evidence (RWE) generation to inform trial design, target populations, unmet needs, disease burden, patient journey, and future asset value.
- Guide economic value assessments (e.g., cost-effectiveness, budget impact, pricing scenarios, health-state utilities) to define product value, support pricing/reimbursement, and shape value narratives.
- Develop early integrated value propositions, value frameworks/narratives, and conduct affiliate touchpoint engagements to shape asset strategy and evidence plans.
- Collaborate with market access on global value dossiers, HTA strategies, access evidence gap closure plans, scenario analyses, and advisory engagements.
- Shape therapeutic area disease area strategies through identification/development of compelling evidence and novel endpoints.
- Communicate research findings and strategic impact to internal and external audiences.
Qualifications:
- Required: Advanced degree in Health Economics, Public Health, Epidemiology, Health Services Research, or related field (Master’s+; PhD or PharmD/MS preferred).
- Minimum experience: 8 years with Master’s or 6 years with PhD/PharmD/MS in progressively senior Health Economics, Outcomes Research, and Market Access roles.
- Strongly preferred: Experience leading COA/PRO evidence generation for pipeline assets in pharma; immunology therapeutic area experience.
- Skills: Strong executive presence/presentation; ability to resolve priority conflicts and operate under resource constraints; deep knowledge of global regulatory/payer/HTA landscape; proven cross-functional global leadership; self-starter with goal-oriented, solution-focused mindset.
Benefits:
- Paid time off (vacation, holidays, sick); medical/dental/vision insurance; 401(k) (eligible employees).
- Short-term incentive programs eligibility.